John Chukinas

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibition”.

DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibition

Leukemia(2025)10.1038/s41375-025-02575-w

N/A

0.219DataRank · unranked

3 citations

Gerald Wertheim, Shikha Gaur, John Chukinas, Joseph P. Loftus, Sung June Lee +15 more

Modulation of CD22 Protein Expression in Childhood Leukemia by Pervasive Splicing Aberrations: Implications for CD22-Directed Immunotherapies

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-21-0087

N/A

0DataRank · unranked

63 citations

Elisabeth Gillespie, Ammar S. Naqvi, Katharina E. Hayer, Zhiwei Ang, Manuel Torres-Diz +17 more

Potent preclinical activity of FLT3-directed chimeric antigen receptor T-cell immunotherapy against FLT3- mutant acute myeloid leukemia and KMT2A-rearranged acute lymphoblastic leukemia

Haematologica(2022)10.3324/haematol.2022.281456

N/A

0DataRank · unranked

53 citations

Zachary Graff, Christopher D. Chien, John Chukinas, Christina A. Meadows, Lillie Leach +5 more

Pharmacologic Inhibition of DYRK1A Results in MYC Hyperactivation and ERK Hyperphosphorylation rendering KMT2A -R ALL Cells Sensitive to BCL2 Inhibition

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.02.510349

N/A

0DataRank · unranked

0 citations

V.S.S. Abhinav Ayyadevara, Gerald Wertheim, John Chukinas, Joseph P. Loftus, Sung June Lee +13 more

CD38 as a pan-hematologic target for chimeric antigen receptor T cells

Blood Advances(2023)10.1182/bloodadvances.2022007059

N/A

0DataRank · unranked

63 citations

Caroline Diorio, John Chukinas, Kimberly Veliz, Olga Shestova, Feng Shen +10 more

Allosteric SHP2 inhibition increases apoptotic dependency on BCL2 and synergizes with venetoclax in FLT3- and KIT-mutant AML

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101290

N/A

0DataRank · unranked

12 citations

Carlos Stahlhut, Theodore C. Tarver, Sydney Wishner, Bianca J. Lee, Cheryl A.C. Peretz +12 more